ERBB2 and invasive ductal breast carcinoma: Less aggressive, unifocal and unilateral lesions are more favorable for cryoablation treatment, such as invasive ductal carcinoma positive for hormone receptor and negative for human epidermal growth factor receptor 2 (HER2) [29].